160 related articles for article (PubMed ID: 3380079)
1. Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths.
Blanton M; McCardy E; Gallaher T; Wang HH
Mol Pharmacol; 1988 Jun; 33(6):634-42. PubMed ID: 3380079
[TBL] [Abstract][Full Text] [Related]
2. Association of a spin-labeled local anesthetic with the allosterically coupled noncompetitive inhibitor site on the acetylcholine receptor.
Palma A; Herz JM; Wang HH; Taylor P
Mol Pharmacol; 1986 Sep; 30(3):243-51. PubMed ID: 3018481
[TBL] [Abstract][Full Text] [Related]
3. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
Arias HR
Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
[TBL] [Abstract][Full Text] [Related]
4. Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor.
Andreeva IE; Nirthanan S; Cohen JB; Pedersen SE
Biochemistry; 2006 Jan; 45(1):195-204. PubMed ID: 16388595
[TBL] [Abstract][Full Text] [Related]
5. Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.
Valenzuela CF; Kerr JA; Duvvuri P; Johnson DA
Mol Pharmacol; 1992 Feb; 41(2):331-6. PubMed ID: 1538711
[TBL] [Abstract][Full Text] [Related]
6. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
Arias HR
Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
[TBL] [Abstract][Full Text] [Related]
7. Does general anesthetic-induced desensitization of the Torpedo acetylcholine receptor correlate with lipid disordering?
Firestone LL; Alifimoff JK; Miller KW
Mol Pharmacol; 1994 Sep; 46(3):508-15. PubMed ID: 7935332
[TBL] [Abstract][Full Text] [Related]
8. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor.
Amitai G; Herz JM; Bruckstein R; Luz-Chapman S
Mol Pharmacol; 1987 Nov; 32(5):678-85. PubMed ID: 3683366
[TBL] [Abstract][Full Text] [Related]
9. Quinacrine noncompetitive inhibitor binding site localized on the Torpedo acetylcholine receptor in the open state.
Johnson DA; Ayres S
Biochemistry; 1996 May; 35(20):6330-6. PubMed ID: 8639577
[TBL] [Abstract][Full Text] [Related]
10. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
Sun H; McCardy EA; Machu TK; Blanton MP
J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
Min CK; Owens J; Weiland GA
Mol Pharmacol; 1994 Feb; 45(2):221-7. PubMed ID: 7509439
[TBL] [Abstract][Full Text] [Related]
12. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
[TBL] [Abstract][Full Text] [Related]
14. Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies.
Ikeda SR; Aronstam RS; Daly JW; Aracava Y; Albuquerque EX
Mol Pharmacol; 1984 Sep; 26(2):293-303. PubMed ID: 6090884
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of phencyclidine binding to the acetylcholine receptor from Torpedo electroplaque.
Oswald RE; Bamberger MJ; McLaughlin JT
Mol Pharmacol; 1984 May; 25(3):360-8. PubMed ID: 6727862
[TBL] [Abstract][Full Text] [Related]
16. Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica.
Lurtz MM; Hareland ML; Pedersen SE
Biochemistry; 1997 Feb; 36(8):2068-75. PubMed ID: 9047305
[TBL] [Abstract][Full Text] [Related]
17. Lipid composition alters drug action at the nicotinic acetylcholine receptor.
Baenziger JE; Ryan SE; Goodreid MM; Vuong NQ; Sturgeon RM; daCosta CJ
Mol Pharmacol; 2008 Mar; 73(3):880-90. PubMed ID: 18055762
[TBL] [Abstract][Full Text] [Related]
18. Association of spin-labeled local anesthetics at the hydrophobic surface of acetylcholine receptor in native membranes from Torpedo marmorata.
Horváth LI; Arias HR; Hankovszky HO; Hideg K; Barrantes FJ; Marsh D
Biochemistry; 1990 Sep; 29(37):8707-13. PubMed ID: 2176831
[TBL] [Abstract][Full Text] [Related]
19. Agonist binding to the Torpedo acetylcholine receptor. 1. Complexities revealed by dissociation kinetics.
Dunn SM; Raftery MA
Biochemistry; 1997 Apr; 36(13):3846-53. PubMed ID: 9092814
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of binding of a benzomorphan opiate to the acetylcholine receptor from Torpedo electroplaque.
Oswald RE; Michel L; Bigelow J
Mol Pharmacol; 1986 Feb; 29(2):179-87. PubMed ID: 3951431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
